{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:26:29Z","timestamp":1761675989304,"version":"build-2065373602"},"reference-count":46,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T00:00:00Z","timestamp":1354579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesia"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    The consumption of illicit substances represents a considerable threat to the health and wellbeing of particular sectors of our communities. Hospitalisation is sometimes required for the treatment of the direct toxic effects of the drugs as well as for injuries sustained while under their influence. Although poisoning with \u2018traditional\u2018 substances of abuse such as opioids, cocaine and cannabis still predominate in terms of numbers, the availability and use of new psychoactive substances are on the rise. These latter agents, some of which began life as failed pharmaceutical products, have enjoyed renewed status as recreational stimulants, entactogens or hallucinogens, properties that originally precluded them from legitimate use. These drugs may act by enhancing endogenous release of neurotransmitters, inhibiting their reuptake back into neurons or having direct effects on receptors, and may involve adrenergic, dopaminergic or serotonergic systems. The use of intravenous lipid emulsion for the symptomatic treatment of drug overdose has become a fertile ground for research and may hold promise as a non\u2010specific treatment for poisoning with illicit substances. Dexmedetomidine, an \u03b1\n                    <jats:sub>2<\/jats:sub>\n                    \u2010receptor agonist with a central sympatholytic effect, may be able to counteract the cardiovascular and central nervous system overstimulation that may accompany stimulant toxicity.\n                  <\/jats:p>","DOI":"10.1111\/anae.12053","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T16:16:50Z","timestamp":1354637810000},"page":"117-124","source":"Crossref","is-referenced-by-count":21,"title":["Poisoning with illicit substances: toxicology for the anaesthetist"],"prefix":"10.1111","volume":"68","author":[{"given":"G. T. C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"e_1_2_16_2_2","article-title":"Deaths: final data for 2009","volume":"60","author":"Kochanek KD","year":"2009","journal-title":"National Vital Statistics Reports"},{"key":"e_1_2_16_3_2","unstructured":"Statistical Bulletin Office for National Statistics 2012 Injury and poisoning mortality England and Wales 2010"},{"key":"e_1_2_16_4_2","doi-asserted-by":"crossref","unstructured":"HoareJ MoonD.Drug misuse declared: findings from the 2009\/10 British Crime Survey 2010.","DOI":"10.1037\/e586982012-001"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.aap.2005.11.005"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.319"},{"key":"e_1_2_16_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.615318"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230412331289482"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2044.2003.03490.x"},{"key":"e_1_2_16_10_2","first-page":"519","article-title":"Drugs of abuse: management of intoxication and antidotes","volume":"100","author":"Montoya ID","year":"2010","journal-title":"EXS"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1974.tb08594.x"},{"key":"e_1_2_16_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432824"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00514-7"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802113180603"},{"key":"e_1_2_16_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198403000-00026"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03017953"},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.188950"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(03)00056-4"},{"key":"e_1_2_16_19_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000246399.10396.15"},{"key":"e_1_2_16_20_2","doi-asserted-by":"publisher","DOI":"10.1213\/00000539-197507000-00003"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199607000-00013"},{"key":"e_1_2_16_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael221"},{"key":"e_1_2_16_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/sa.2000.9041"},{"key":"e_1_2_16_24_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v15n04_05"},{"key":"e_1_2_16_25_2","first-page":"917","article-title":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs","volume":"165","author":"Kalant H","year":"2001","journal-title":"Canadian Medical Association Journal"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/ael078"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02080508"},{"key":"e_1_2_16_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.3.454"},{"key":"e_1_2_16_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-197204000-00010"},{"key":"e_1_2_16_30_2","first-page":"161","article-title":"Amphetamine abuse in pregnancy: anesthetic implications","volume":"54","author":"Kuczkowski KM","year":"2003","journal-title":"Acta Anaesthesiologica Belgica"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.645952"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/dta.313"},{"key":"e_1_2_16_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90380-1"},{"key":"e_1_2_16_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.572076"},{"key":"e_1_2_16_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06184_23.x"},{"key":"e_1_2_16_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05744.x"},{"key":"e_1_2_16_37_2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/EJA.0b013e3283357049","article-title":"Intralipid reverses coma associated with zopiclone and venlafaxine overdose","volume":"27","author":"Hillyard SG","year":"2010","journal-title":"European Journal of Anaesthesiology"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2011.06895.x"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.617308"},{"key":"e_1_2_16_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2011.06690.x"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2009.00499.x"},{"key":"e_1_2_16_42_2","doi-asserted-by":"publisher","DOI":"10.3109\/15563650903544124"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0b013e31816b9415"},{"key":"e_1_2_16_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.03.060"},{"key":"e_1_2_16_45_2","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/174132"},{"key":"e_1_2_16_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200209000-00024"},{"key":"e_1_2_16_47_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5863\/1551-6776-15.1.43","article-title":"Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents","volume":"15","author":"Tobias JD","year":"2010","journal-title":"Journal of Pediatric Pharmacology and Therapeutics"}],"container-title":["Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fanae.12053","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/anae.12053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:37:06Z","timestamp":1761669426000},"score":1,"resource":{"primary":{"URL":"https:\/\/associationofanaesthetists-publications.onlinelibrary.wiley.com\/doi\/10.1111\/anae.12053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,4]]},"references-count":46,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/anae.12053"],"URL":"https:\/\/doi.org\/10.1111\/anae.12053","archive":["Portico"],"relation":{},"ISSN":["0003-2409","1365-2044"],"issn-type":[{"type":"print","value":"0003-2409"},{"type":"electronic","value":"1365-2044"}],"subject":[],"published":{"date-parts":[[2012,12,4]]}}}